Vertigo: Causes, Red Flags, Treatment & When to See a Doctor

## Overview Vertigo is the illusory sensation that you or your surroundings are spinning, tilting, or moving when no actual motion is occurring. It is not a disease itself but a symptom arising from dysfunction in the vestibular system — the network of inner-ear structures and brain pathways responsible for balance and spatial orientation. Vertigo is classified under ICD-10 codes **H81** (disorders of vestibular function) and **R42** (dizziness and giddiness). Vertigo is remarkably common. Population-based studies estimate a one-year prevalence of approximately 5–10% in the general adult population, with lifetime prevalence reaching 20–30% [1]. Women are affected roughly two to three times more often than men, and prevalence increases with age, peaking between 60 and 80 years. In the United States alone, vertigo and dizziness account for approximately 4 million emergency department visits annually. People search for information about vertigo because episodes can be frightening, disabling, and recurrent. Many sufferers worry they are having a stroke, and distinguishing between benign and life-threatening causes is critical. This article provides an evidence-based overview of vertigo causes, warning signs, home care, medications, diagnostic testing, and guidance on when to seek medical attention. It is important to distinguish vertigo from other forms of dizziness such as presyncope (a feeling of nearly fainting), disequilibrium (unsteadiness without a spinning sensation), and non-specific lightheadedness. True vertigo implies vestibular system involvement and generally points to a more specific set of diagnoses [2]. ## Common Causes Vertigo is broadly divided into **peripheral** causes (arising from the inner ear or vestibular nerve) and **central** causes (arising from the brainstem or cerebellum). Peripheral causes account for roughly 80% of vertigo presentations [3]. ### Peripheral Causes (Most Common) **1. Benign Paroxysmal Positional Vertigo (BPPV)** — the single most common cause, responsible for approximately 20–30% of all vertigo cases. BPPV occurs when calcium carbonate crystals (otoconia) become dislodged from the utricle and migrate into one of the semicircular canals, most often the posterior canal. Head movements cause these displaced crystals to shift within the canal, creating abnormal endolymph flow that stimulates hair cells inappropriately. This produces brief (typically < 60 seconds) but intense episodes of spinning triggered by specific head positions — rolling over in bed, looking up, or bending forward [4]. **2. Vestibular neuritis / labyrinthitis** — the second most common peripheral cause. Vestibular neuritis involves inflammation of the vestibular nerve, usually following a viral upper respiratory infection. When the cochlea is also involved (causing hearing loss and tinnitus), the condition is termed labyrinthitis. The pathophysiology involves viral-induced inflammation and demyelination of the vestibular nerve, creating an asymmetry in tonic vestibular input to the brainstem. This produces acute, severe, continuous vertigo lasting days to weeks [5]. **3. Ménière disease** — affects roughly 0.2% of the population. It results from endolymphatic hydrops — excess fluid accumulation in the endolymphatic compartment of the inner ear. The mechanism likely involves impaired endolymph absorption by the endolymphatic sac. Classic presentation includes episodic vertigo (lasting 20 minutes to several hours), fluctuating low-frequency sensorineural hearing loss, tinnitus, and aural fullness [6]. **4. Vestibular migraine** — increasingly recognized as a common cause, affecting approximately 1% of the general population. The pathophysiology is incompletely understood but likely involves aberrant activation of trigeminovascular pathways and reciprocal connections between vestibular nuclei and pain-processing regions. Episodes may or may not coincide with headache and can last minutes to days. **5. Other peripheral causes** — acoustic neuroma (vestibular schwannoma), ototoxic medications (aminoglycosides, cisplatin, loop diuretics), perilymphatic fistula, and superior semicircular canal dehiscence syndrome. ### Central Causes (Less Common but More Serious) **1. Cerebellar or brainstem stroke/TIA** — posterior circulation ischemia can present with isolated vertigo, particularly infarction of the cerebellum (especially the inferior cerebellum) or lateral medulla. This is the most dangerous "do not miss" diagnosis [7]. **2. Multiple sclerosis** — demyelinating plaques in the brainstem or cerebellar peduncles can produce vertigo, often in younger adults. **3. Posterior fossa tumors** — meningiomas, metastases, or other lesions compressing the brainstem or cerebellum. **4. Chiari malformation** — downward herniation of the cerebellar tonsils through the foramen magnum. ## RED FLAGS The following signs and symptoms in a patient with vertigo may indicate a central (potentially life-threatening) cause and warrant **immediate emergency evaluation** (call 911 or go to the ER): - **New, acute vertigo with any focal neurological deficit**: limb weakness, numbness, facial droop, slurred speech (dysarthria), double vision (diplopia), difficulty swallowing (dysphagia) - **Severe headache** — especially sudden-onset ("thunderclap") headache accompanying vertigo, raising concern for cerebellar hemorrhage or vertebral artery dissection - **Inability to walk or stand** (severe truncal ataxia) — particularly if disproportionate to the degree of vertigo - **Direction-changing nystagmus** or purely vertical/torsional nystagmus not fitting BPPV patterns — suggests central pathology - **Acute hearing loss with vertigo and new headache** — may indicate labyrinthine infarction or autoimmune inner ear disease - **Vertigo with neck pain after trauma or neck manipulation** — raises concern for vertebral artery dissection - **Persistent vomiting with inability to keep down fluids** — risk of dehydration and may indicate central lesion - **Known vascular risk factors** (hypertension, diabetes, atrial fibrillation, smoking, advanced age) with new acute vertigo — increases pre-test probability of stroke - **Recent head trauma** followed by vertigo with altered consciousness > **Important:** The HINTS exam (Head Impulse, Nystagmus, Test of Skew) performed by trained clinicians has been shown to be more sensitive than early MRI for detecting posterior circulation stroke in the acute vestibular syndrome [7]. If you experience acute, continuous vertigo lasting hours with any of the above features, seek emergency care immediately. ## Self-Care at Home For vertigo that has been evaluated by a clinician and attributed to a benign cause, or for mild recurrent episodes consistent with a known diagnosis such as BPPV, the following evidence-based non-pharmacological measures may help: ### Canalith Repositioning Maneuvers (for BPPV) - **Epley maneuver** — a series of sequential head and body position changes designed to move displaced otoconia out of the affected semicircular canal back into the utricle. A Cochrane review found the Epley maneuver significantly more effective than sham maneuver or no treatment, with resolution rates of approximately 80% after one to three treatments [8]. The maneuver can be performed at home after initial instruction by a healthcare professional, though effectiveness may be reduced without proper technique. - **Brandt-Daroff exercises** — a habituation exercise involving repeated side-to-side lying movements. Generally considered less effective than the Epley maneuver for posterior canal BPPV but may be useful as a home supplement. ### Vestibular Rehabilitation Therapy (VRT) A structured program of exercises designed to promote central nervous system compensation for vestibular deficits. VRT typically includes gaze stabilization exercises, habituation exercises, and balance training. Multiple randomized trials support its efficacy for chronic unilateral vestibular hypofunction and persistent dizziness following vestibular neuritis [5]. VRT is best initiated under the guidance of a physiotherapist trained in vestibular rehabilitation. ### Lifestyle and Behavioral Measures - **Hydration** — dehydration can worsen dizziness; maintaining adequate fluid intake is generally advisable - **Sleep positioning** — for BPPV, sleeping with the head slightly elevated (30°) and avoiding the provocative side may reduce nocturnal episodes - **Fall prevention** — remove trip hazards, use nightlights, install grab bars in bathrooms; particularly important in older adults - **Dietary modifications for Ménière disease** — a low-sodium diet (< 2 g/day) is commonly recommended, though high-quality evidence is limited. Limiting caffeine and alcohol may also help reduce episode frequency in some individuals - **Stress management and adequate sleep** — stress and sleep deprivation are recognized triggers for vestibular migraine - **Avoid rapid head movements** during acute episodes; move slowly and deliberately ### What to Avoid - Driving or operating heavy machinery during active vertigo episodes - Working at heights or in situations where sudden loss of balance could be dangerous - Excessive use of vestibular suppressant medications beyond the acute phase, as these may delay central compensation ## OTC Medications That Help Over-the-counter vestibular suppressants and antiemetics may provide symptomatic relief during acute vertigo episodes. These should generally be used for **short-term relief only** (typically ≤ 3 days) as prolonged use can impair central vestibular compensation [3]. | Class | Example | Adult Dose | Notes | |---|---|---|---| | Antihistamine (H1 blocker) | **Meclizine** (Antivert, Bonine) | 25–50 mg every 6–8 hours as needed | First-line OTC vestibular suppressant. Anticholinergic properties contribute to efficacy. May cause drowsiness. Avoid in glaucoma, prostatic hypertrophy. | | Antihistamine (H1 blocker) | **Dimenhydrinate** (Dramamine Original) | 50–100 mg every 4–6 hours (max 400 mg/day) | Similar mechanism to meclizine. More sedating. Avoid with MAOIs. | | Antihistamine (H1 blocker) | **Diphenhydramine** (Benadryl) | 25–50 mg every 6–8 hours | Significant sedation. Anticholinergic side effects (dry mouth, urinary retention, constipation). Use with caution in elderly (Beers Criteria). | | Antiemetic (ginger) | **Ginger supplements** | 250 mg four times daily or ginger tea | Some evidence for nausea relief; limited evidence specifically for vertigo-related nausea. Generally well tolerated. May increase bleeding risk with anticoagulants. | **Key considerations:** - Meclizine is generally preferred due to its favorable sedation profile relative to efficacy - All antihistamine-type vestibular suppressants carry anticholinergic effects; use cautiously in patients with narrow-angle glaucoma, benign prostatic hyperplasia, or urinary retention - These medications treat the symptom, not the underlying cause — proper diagnosis is essential - Do not use vestibular suppressants for more than 72 hours without medical guidance, as they may impede natural vestibular compensation ## Prescription Options Prescription medications are generally warranted when vertigo is severe, recurrent, or attributable to specific diagnoses requiring targeted therapy. | Class | Example | Indication | Notes | |---|---|---|---| | Benzodiazepine (vestibular suppressant) | **Diazepam** 2–5 mg PO q8–12h; **Lorazepam** 0.5–1 mg PO q8h | Acute severe vertigo (short-term, typically ≤ 3 days) | Enhances GABA-A activity, suppressing vestibular nucleus firing. Risk of dependence — short-term use only. Prescribed by ER physicians, ENTs, neurologists. | | Corticosteroid | **Methylprednisolone** taper or **Prednisone** 1 mg/kg/day taper over 3 weeks | Vestibular neuritis | May improve long-term vestibular recovery. A randomized trial showed methylprednisolone improved caloric testing outcomes vs. placebo [5]. Prescribed by ENTs, neurologists. | | Antiemetic (phenothiazine) | **Promethazine** 12.5–25 mg PO/PR/IM q6h; **Prochlorperazine** 5–10 mg PO/IM q6–8h | Severe nausea/vomiting with vertigo | Dopamine antagonist with antihistaminic properties. Risk of extrapyramidal symptoms. Avoid in Parkinson disease. | | Antiemetic (5-HT3 antagonist) | **Ondansetron** 4–8 mg PO/IV q8h | Severe nausea unresponsive to other agents | Serotonin receptor antagonist. Less sedation than phenothiazines. May prolong QTc at higher doses. | | Diuretic | **Hydrochlorothiazide** 25–50 mg daily; **Acetazolamide** 250 mg daily–BID | Ménière disease (maintenance) | Aims to reduce endolymphatic pressure. Evidence is limited but widely used in practice. Monitor electrolytes. Prescribed by ENTs. | | Betahistine | **Betahistine** 8–16 mg TID | Ménière disease (widely used outside the US) | Histamine H3 antagonist / H1 agonist. Improves microcirculation in the inner ear. Not FDA-approved in the US but available in Europe and many other countries [6]. | | Migraine prophylactic | **Topiramate**, **Amitriptyline**, **Venlafaxine**, **Propranolol** | Vestibular migraine (prophylaxis) | Standard migraine preventives adapted for vestibular migraine based on expert consensus; large RCTs are ongoing. Prescribed by neurologists. | | Intratympanic therapy | **Gentamicin** or **Dexamethasone** injection | Refractory Ménière disease | Gentamicin ablates vestibular hair cells (risk of hearing loss); dexamethasone is a safer alternative. Administered by ENT specialists. | **Who prescribes:** Primary care physicians can manage uncomplicated BPPV and prescribe short-term vestibular suppressants. Persistent, recurrent, or diagnostically uncertain vertigo should be referred to an **otolaryngologist (ENT)** or **neurologist**. Vestibular migraine is typically managed by a neurologist or headache specialist. ## Lab Tests Typically Ordered Vertigo evaluation relies heavily on clinical history and physical examination. However, several tests may be ordered to establish the diagnosis, identify underlying causes, or rule out dangerous conditions: | Test | Rationale | |---|---| | **Audiometry** (pure tone and speech) | Essential in evaluating Ménière disease, acoustic neuroma, and labyrinthitis. Identifies sensorineural vs. conductive hearing loss patterns. | | **MRI brain with contrast** (focused on posterior fossa / internal auditory canals) | Gold standard for ruling out acoustic neuroma, posterior fossa tumors, demyelinating lesions, or stroke (though sensitivity for acute ischemic stroke is limited in the first 24–48 hours). | | **CT head** | Used in emergency settings to rule out cerebellar hemorrhage. Less sensitive than MRI for ischemia. | | **Videonystagmography (VNG)** / Electronystagmography (ENG) | Evaluates nystagmus patterns and vestibular function; helps localize the lesion to peripheral vs. central structures. | | **Caloric testing** | Part of the VNG battery; assesses horizontal semicircular canal function on each side. Unilateral weakness suggests peripheral vestibular hypofunction. | | **CT angiography (CTA) or MR angiography (MRA)** of head and neck | When vertebral artery dissection or posterior circulation stenosis is suspected. | | **Basic metabolic panel (BMP)** | Screens for electrolyte abnormalities, dehydration, or renal dysfunction that can contribute to dizziness. [See: /tests/basic-metabolic-panel] | | **Complete blood count (CBC)** | Evaluates for anemia (a cause of non-vestibular dizziness) and infection. [See: /tests/complete-blood-count] | | **Thyroid function tests (TSH)** | Thyroid dysfunction can cause non-specific dizziness and should be excluded. [See: /tests/thyroid-function-tests] | | **Glucose / HbA1c** | Diabetes is a vascular risk factor and can cause peripheral neuropathy affecting balance. [See: /tests/hba1c] | | **Dix-Hallpike test** | A bedside positional test — not a lab test per se, but the most important diagnostic maneuver for posterior canal BPPV. A positive test (transient torsional upbeating nystagmus with latency and fatigability) is diagnostic [4]. | | **VEMP (Vestibular Evoked Myogenic Potentials)** | Evaluates saccule and utricle function; useful in diagnosing superior canal dehiscence and Ménière disease. | ## Special Populations ### Children Vertigo in children is less common than in adults but not rare. The most common causes include benign paroxysmal vertigo of childhood (a migraine equivalent, distinct from BPPV), vestibular migraine, and otitis media with labyrinthine involvement. BPPV is uncommon in children under age 10. - Evaluation should include careful neurological examination to exclude posterior fossa pathology - Meclizine is generally not recommended for children under 12 years without specific pediatric guidance - Dimenhydrinate may be used in children ≥ 2 years at weight-based dosing per the prescribing clinician - **Do not administer adult OTC vestibular suppressant doses to children** — consult a pediatrician or pediatric ENT specialist - Vestibular rehabilitation can be adapted for children and is generally safe and effective ### Pregnancy - Vertigo may occur or worsen during pregnancy due to hormonal changes, fluid shifts, and increased blood volume - **Meclizine** is classified as FDA Pregnancy Category B (no evidence of fetal risk in animal studies; limited human data). It is generally considered acceptable for short-term use in pregnancy when benefits outweigh risks - **Dimenhydrinate** is also Category B and is commonly used for nausea in pregnancy in some countries - **Benzodiazepines** should be avoided, particularly in the first trimester (risk of oral cleft) and near term (risk of neonatal sedation and withdrawal) - The Epley maneuver and vestibular rehabilitation are safe and preferred as first-line treatments in pregnancy - Pregnant patients with new-onset vertigo should be evaluated promptly to exclude pre-eclampsia (which can present with neurological symptoms) and other pregnancy-specific conditions ### Elderly - Vertigo and dizziness are among the most common complaints in adults over age 65, with a prevalence approaching 30% - BPPV incidence peaks in the 60–80 age group due to age-related degeneration of otoconia - **Fall risk** is the primary concern — vertigo is a significant contributor to falls in older adults, leading to fractures, head injuries, and loss of independence - Anticholinergic vestibular suppressants (meclizine, diphenhydramine, dimenhydrinate) should be used with great caution due to increased susceptibility to sedation, confusion, urinary retention, and falls. Diphenhydramine is listed on the **American Geriatrics Society Beers Criteria** as potentially inappropriate in older adults [9] - Benzodiazepines carry heightened risk of falls, cognitive impairment, and paradoxical agitation in the elderly - Central causes of vertigo (stroke, TIA) become more likely with advancing age and vascular risk factors — maintain a lower threshold for neuroimaging - Vestibular rehabilitation is effective and safe in elderly patients and should be considered first-line ### Athletes - Post-concussion vertigo is common following sports-related head injuries and may indicate BPPV (from traumatic otoconia displacement), vestibular nerve injury, or central vestibular dysfunction - BPPV following concussion may respond to canalith repositioning maneuvers - Vestibular rehabilitation is a key component of concussion recovery protocols - Return-to-play decisions should not be made until vertigo and balance deficits have fully resolved - Vestibular suppressant medications may impair reaction time and coordination — athletes should not return to competition while taking these medications - Scuba divers presenting with vertigo after diving should be evaluated for **perilymphatic fistula** and **alternobaric vertigo**; decompression sickness must be excluded ## When to Escalate The appropriate urgency of evaluation depends on the clinical scenario: ### Call 911 / Go to the Emergency Room Immediately - Vertigo with **any** new neurological symptoms (weakness, numbness, speech difficulty, vision changes, severe headache, difficulty walking) - Vertigo after head or neck trauma with altered consciousness - Vertigo with sudden severe headache (concern for hemorrhagic stroke) - Vertigo with chest pain, shortness of breath, or irregular heartbeat - Inability to stand or walk due to severe imbalance - Persistent vomiting with inability to maintain hydration ### See a Doctor the Same Day (Urgent Care or GP) - First episode of significant vertigo without clear positional trigger - Vertigo accompanied by new hearing loss or tinnitus - Vertigo lasting continuously for more than 24 hours - Vertigo with fever (concern for labyrinthitis or CNS infection) - Vertigo with recent ear infection ### Schedule a GP or Specialist Appointment Within 1–2 Weeks - Recurrent brief positional vertigo episodes consistent with BPPV (for confirmation and canalith repositioning) - Persistent mild dizziness or unsteadiness following an acute vertigo episode (for vestibular rehabilitation referral) - Known Ménière disease with increasing episode frequency - Vertigo associated with migraine headaches (for vestibular migraine evaluation) ### Specialist Referral Indications - **ENT/Otolaryngologist**: recurrent BPPV not responding to repositioning maneuvers, suspected Ménière disease, unilateral hearing loss, consideration of intratympanic therapy - **Neurologist**: suspected vestibular migraine, vertigo with abnormal neurological examination, recurrent vertigo of unclear etiology, demyelinating disease - **Vestibular physiotherapist**: persistent imbalance, vestibular hypofunction, post-concussion vestibular dysfunction - **Neuro-ophthalmologist**: complex nystagmus patterns, visual-vestibular mismatch ## References [1] Neuhauser HK. The epidemiology of dizziness and vertigo. *Handb Clin Neurol*. 2016;137:67-82. PMID:27638063. [2] Kerber KA, Baloh RW. The evaluation of a patient with dizziness. *Neurol Clin Pract*. 2011;1(1):24-33. PMID:23634356. [3] Thompson TL, Amedee R. Vertigo: a review of common peripheral and central vestibular disorders. *Ochsner J*. 2009;9(1):20-26. PMID:21603405. [4] Bhattacharyya N, Gubbels SP, Schwartz SR, et al. Clinical Practice Guideline: Benign Paroxysmal Positional Vertigo (Update). *Otolaryngol Head Neck Surg*. 2017;156(3_suppl):S1-S47. PMID:28248609. [5] Strupp M, Dieterich M, Brandt T. The treatment and natural course of peripheral and central vertigo. *Dtsch Arztebl Int*. 2013;110(29-30):505-515. PMID:23964303. [6] Basura GJ, Adams ME, Monfared A, et al. Clinical Practice Guideline: Ménière's Disease. *Otolaryngol Head Neck Surg*. 2020;162(2_suppl):S1-S55. PMID:32267799. [7] Edlow JA, Newman-Toker DE. Using the physical examination to diagnose patients with acute dizziness and vertigo. *J Emerg Med*. 2016;50(4):617-628. PMID:26899826. [8] Hilton MP, Pinder DK. The Epley (canalith repositioning) manoeuvre for benign paroxysmal positional vertigo. *Cochrane Database Syst Rev*. 2014;(12):CD003162. PMID:25485940. [9] American Geriatrics Society 2019 Updated AGS Beers Criteria for Potentially Inappropriate Medication Use in Older Adults. *J Am Geriatr Soc*. 2019;67(4):674-694. PMID:30693946. [10] NICE Clinical Knowledge Summaries. Vertigo. National Institute for Health and Care Excellence. Last revised 2023. Available at: https://cks.nice.org.uk/topics/vertigo/ --- *Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional for diagnosis and treatment of vertigo or any medical condition. If you experience vertigo with neurological symptoms, seek emergency medical care immediately.*